Pretreatment with AG490 and P1-TKIP JAK2 inhibitory peptide blocked CXCL12-triggered static adhesion of CLL B-lymphocytes to both ICAM-1 and VCAM-1 (Figures 5C and 5D). This evidence concerns the gene JAK2 and B-cell chronic lymphocytic leukemia.